Our mission is to improve the health of low resource communities through the integration of innovative research, quality education and service, and inter-professional collaborations in pediatric health.
Develop GH policies to support fundable, sustainable, feasible, novel and impactful programs.
Develop GH guidelines emphasizing interprofessional collaborations; cultural immersion; the importance of full partnership, shared responsibility, evidence-based interventions, and system-strengthening approaches to GH.
Collaborate with UIC Center for Global Health and reach out to UIC partners for resource sharing and exchange of ideas.
Implement outcome assessment for all of the GH activities toward publishable and fundable GH program.
Thirty percent of the burden in global health is surgical in nature
Half of the surgical needs in the world are life-threatening
LMIC patients with injuries have a 6-10 fold higher mortality rate
The Lancet commission on Global Surgery 2030 recently defined its sustainable development goals for global health to include universal access to timely, safe and affordable surgical and anesthesia care
Surgery is the neglected stepchild of Global Health while Pediatric Surgery is the unborn child of Global Health
WHAT WE ARE
IPSAC-VN (International Pediatric Specialists Alliance for the Children of VietNam): A philanthropic organization with 501(c) (3) status, incorporated in 2009 in the US and in 2016 in Vietnam. Our volunteers are academic professionals of varying pediatric specialties (pediatric surgery/urology/ENT, anesthesiology, oncology, critical care, emergency medicine, neonatology, pediatric surgical nurse practitioners) from health care institution inside and outside the US.
Our mission is to enhance the care of the children in Vietnam through partnership with Vietnamese health care professionals to enhance the workforce and build the institutional capacity in pediatric.
WHAT WE DO
Workforce building and workforce skill enhancement activities for pediatric surgery and pediatric subspecialties at VN pediatric institutions through
Clinical program development such as quality improvement and patient safety initiatives
Educational and training projects such as a new resuscitation course in pediatric acute surgical emergencies (PASS) for first responders in low resources facilities. The course currently targets future trainers of the first responders
Support of academic activities such as manuscript preparations, publications, and scientific presentations
Promotion of research activities such as an interventional clinical trial under a FDA IND, and innovative translational investigations
Our sites of operation include medical universities in the South of Vietnam, and 6 children hospitals in the North, Central and South of Vietnam.
Residents and fellows participation in of our activities is site- and program-dependent. We make more than twice a year visits to VN. The frequency of the visit at any of the sites is a function of their programmatic needs.
For additional information, please visit our website at IPSACVIETNAM.ORG
Much progress has been made in management and cure of sickle cell disease in the USA, but a huge population of sickle cell patients in Nigeria has not benefited from this progress. Early diagnosis through newborn screening is fundamental to better care. I have experience with sickle cell care and newborn screening, and I’d like to help Nigeria establish newborn screening programs. I have found partners in several academic medical centers in Nigeria, plus Nigerian expatriates in England who can bridge the cultural, medical, and political differences between US and Nigeria. We can also benefit from genetic the large populations
WHAT ARE WE
Loose collaborative group. Chicago: UIHealth sickle cell center, pediatric and adult, including bone marrow transplant team, Loyola University Med Center at Maywood.
Nigeria: University of Ibadan, Kaduna State University, Bingham University, Bowen University. United Kingdom: Kings College, Guys and St Thomas Hospital, Oxford University Hospital.
We have written 2 papers together with University of Ibadan, on genomics and on a demonstration trial of hydroxyurea safety and feasibility. I have participated in several grant applications for newborn screening for sickle cell in Nigeria (European Union Marie Curie RISE program, Wellcome Trust, British NHS, Children’s Prize) This video pitches the need and the main ideas we are trying to get funded.
Introduces the proposal for “Scalable, low-cost, community-based screening and treatment of newborns with sickle cell disease” for Ibadan district of Nigeria…
GEOGRAPHIC AND SOCIOECONOMIC BACKGROUND
Nigeria is the most populous country in Africa. The estimated number of Nigerian babies with sickle cell disease is about 100,000 per year, which is more than the total number of Americans of all ages living with sickle cell disease. Nigeria has oil wealth and a lot of economic growth but big disparities in income. The militant group Boko Haram in the north has caused violence for many years. There are multiple ethnic and linguistic groups, and Kaduna state is a microcosm of the country’s diversity. The governor of Kaduna state has decided to fund newborn screening for sickle cell disease as a demonstration of feasibility.
WHAT ARE WE
Setting up newborn screening services in Kaduna state Nigeria will use my prior experience in several states on sickle cell newborn screening. The team will draw upon the programs for newborn screening in Ghana, USA, and UK. We will also use Implementation Science approaches and a range of community health workers to adapt the programs to the needs of Nigeria. I plan to visit Abuja, Nigeria, in Feb 2018 to help launch the newborn screening program by training staff there to train Community Health Workers and to use Implementation Science. With my adult sickle hematologist colleagues, we published a couple papers with the group in Ibadan, Nigeria.
1: Saraf SL, Akingbola TS, Shah BN, Ezekekwu CA, Sonubi O, Zhang X, Hsu LL, Gladwin MT, Machado RF, Cooper RS, Gordeuk VR, Tayo BO. Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts. Blood Adv. 2017 Apr 25;1(11):693-698.
PubMed PMID: 28868518;
PubMed Central PMCID:
2: Akingbola TS, Tayo BO, Salako B, Layden JE, Hsu LL, Cooper RS, Gordeuk VR, Saraf SL. Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications. Hemoglobin. 2014;38(4):236-43. doi: 10.3109/03630269.2014.927363. Epub 2014 Jun 18.
PubMed PMID: 24941131; PubMed Central PMCID: PMC4161131.
The Clinical Effort Against Secondhand Smoke Exposure (CEASE) clinical curriculum is designed to help clinicians address family tobacco use and secondhand smoke exposure in a routine and effective manner. CEASE was developed and tested via extensive research in the United States (US) and our team has demonstrated its effectiveness in pediatric settings in the US and in China. The proposed project aims to adapt and test the CEASE intervention for use in clinical settings in Kenya and to build the tobacco control research-capacity of investigators, pediatricians, community health workers and clinical practice in Kenya. Our ultimate goal is to assess the impact of these interventions on tobacco-related outcomes. The Specific Aims of the proposed project are to: 1: Develop an adaptation of the CEASE tobacco intervention for child healthcare physicians and community health workers in Kenya to address parental smoking and the secondhand smoke exposure of children and other nonsmokers; 2: Test the feasibility and acceptability of CEASE tobacco interventions in clinical settings in Kenya; and 3: Build the research capacity of child healthcare physicians, community health workers and other stakeholders via collaboration in the development and practice-based testing of the CEASE intervention.
Jonathan D. Klein, MD, MPH Professor and Senior Associate Department Head Department of Pediatrics University of Illinois at Chicago firstname.lastname@example.org
INSTRUCTIONS: In order to add a sidebar anchor:
Duplicate the existing item, listed as a 1/6 text field. (Or create a 1/6 column and add a text field, modify the class so it’s exactly “additionalAnchor”).
Modify the text field inside the 1/6 column. Inside there, modify the HYPERLINK so that it would go to a corresponding section with a “#” in front of it. (Example, we have a “chief” section on the page, then it would make sense to have the hyperlink go to “#chief”)
Then change the hyperlink TEXT to a appropriate label.
IMPORTANT: If not done already, go into that CONTAINER that corresponds to your anchor (i.e. Meet The Chiefs), and add an ID matching the anchor’s HYPERLINK WITHOUT the “#”, i.e. “chief”.
(If using side bar widget box, then there’s a saved copy of a widget box COLUMN, grab it in the column library, it should 1/6 of a length of a column.)
NOTE: Order added to the sidebar is from last to first.